Additional file 1: Table S1. of Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Investigator-assessed response across patient subgroups (efficacy-evaluable patients). Assessments and demographics for patients with metastatic BCC and locally advanced BCC. (DOCX 16Â kb